GNOM vs SCHD
Global X Genomics & Biotechnology ETF vs Schwab US Dividend Equity ETF
Quick Verdict
SCHD has a lower expense ratio. GNOM delivered stronger 1-year returns. SCHD offers more diversification with 100 holdings.
Side-by-Side Comparison
| Metric | GNOM | SCHD | Winner |
|---|---|---|---|
| Expense Ratio | 0.50% | 0.06% | |
| AUM | $79M | $103.7B | |
| Dividend Yield | 1.15% | 3.31% | |
| Holdings | 52 | 104 | |
| YTD Return | +30.83% | +25.62% | |
| 1Y Return | +73.35% | +32.62% | |
| 3Y Return (annualized) | +10.25% | +15.58% | |
| 5Y Return (annualized) | -8.20% | +9.63% | |
| Volatility (annualized) | 29.8% | 13.6% | |
| Max Drawdown | -75.0% | -33.4% | |
| Fund Family | Global X by mirae Asset | Charles Schwab Asset Management | |
| Category | Equity | Equity | |
| Inception | Apr 5, 2019 | Oct 20, 2011 |
GNOM vs SCHD Performance
Global X Genomics & Biotechnology ETF (GNOM) is a ETF from Global X by mirae Asset and Schwab US Dividend Equity ETF (SCHD) is a ETF from Charles Schwab Asset Management. Over the past year GNOM returned +73.35% while SCHD returned +32.62%. Year to date, GNOM is up 30.83% versus a gain of 25.62% for SCHD.
Over three years, GNOM compounded at +10.25% per year against +15.58% for SCHD; over five years the annualized figures are -8.20% and +9.63% respectively. Across the full 7-year window we track, SCHD has the edge at +11.47% annualized vs -0.18%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
GNOM has been the more volatile fund, with annualized monthly volatility of 29.8% compared with 13.6% for SCHD. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -75.0% for GNOM and -33.4% for SCHD. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.46. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
GNOM charges 0.50% per year while SCHD charges 0.06%. On a $10,000 position that is $50 vs $6 annually, a gap of $44 per year that compounds over a long holding period. On income, GNOM currently yields 1.15% against 3.31% for SCHD.
Holdings Overlap
GNOM and SCHD share 1 holdings out of 134 unique holdings combined, representing a 3.2% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Top Shared Holdings
| Stock | Weight in GNOM | Weight in SCHD | Difference |
|---|---|---|---|
| BMY | 3.36% | 3.22% | 0.14% |
Frequently Asked Questions
Which is cheaper, GNOM or SCHD?
GNOM has an expense ratio of 0.50% while SCHD charges 0.06%. SCHD is the cheaper option. On a $10,000 investment, that is $44 per year of difference.
Which performed better, GNOM or SCHD?
Over the past year GNOM returned +73.35% vs +32.62% for SCHD, so GNOM leads on 1-year performance. Over the longest common window we track (7 years), GNOM annualized -0.18% vs +11.47% for SCHD. Past performance does not guarantee future results.
Which is riskier, GNOM or SCHD?
GNOM has been the more volatile fund at 29.8% annualized versus 13.6% for SCHD. Worst drawdown: GNOM -75.0% vs SCHD -33.4%.
Should I hold both GNOM and SCHD?
GNOM and SCHD have a monthly-return correlation of 0.46, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between GNOM and SCHD?
GNOM and SCHD share 1 common holdings with a 3.2% weight overlap. Combined, they hold 134 unique securities.
Which pays a higher dividend, GNOM or SCHD?
GNOM yields 1.15% while SCHD yields 3.31%, so SCHD currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.